Mission statement
The European Malignant Hyperthermia (MH) Group was formed in 1983 with the following aims:
- to provide a forum for discussion between the various European MH investigation centers
- to improve, maintain and update the quality of diagnostic standards of MH susceptibility
- to increase knowledge about MH for the medical community and for patients
- to promote inter-laboratory scientific research on MH
- to establish a common database
- to promote research into the molecular aetiology and new pharmacologically-based treatments of MH
